Targeting YAP suppresses ovarian cancer progression through regulation of the PI3K/Akt/mTOR pathway-Reference-Cited by-同舟云学术

Targeting YAP suppresses ovarian cancer progression through regulation of the PI3K/Akt/mTOR pathway

Published:2019-10-14 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Wei Xiao¹,Jia Yijuan²,Lou Hua¹,Ma Jingjing¹,Huang Quanfu³,Meng Yunchong³,Sun Chaoyang¹,Yang Zongyuan¹,Li Xiaoting¹,Xu Sen¹,Yang Xin¹,Ji Teng¹,Gao Qinglei¹

Affiliation:

1. Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China

2. Department of Obstetrics and Gynecology, Wuhan First Hospital, Wuhan, Hubei 430030, P.R. China

3. Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway;International Journal of Oncology;2024-06-14

2. YAP condensates are highly organized hubs;iScience;2024-06

3. Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment;Frontiers in Pharmacology;2023-08-17

4. Insights into recent findings and clinical application of YAP and TAZ in cancer;Nature Reviews Cancer;2023-06-12

5. Integrins in Ovarian Cancer: Survival Pathways, Malignant Ascites and Targeted Photochemistry;Recent Advances, New Perspectives and Applications in the Treatment of Ovarian Cancer;2023-01-18